Researchers Launching Larger Trials To Study Effectiveness Of Nirmatrelvir/Ritonavir As Long COVID Treatment

November 30, 2022

TIME (11/29, Ducharme) reports, “Researchers don’t fully understand why some people develop long-lasting symptoms after a case of COVID-19, but one of the leading theories is that remnants of the virus linger in some people’s bodies, causing lasting issue...